Canada Pension Plan Investment Board’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
DTC
Canada Pension Plan Investment Board's AXSM Position: Q2 2026 in Review
Canada Pension Plan Investment Board increased its Axsome Therapeutics (AXSM) stake by 147% in Q2 2026, buying an estimated $29.1M and bringing the position to 225,400 shares worth $55.2M. The position accounts for 0.03% of the portfolio, ranked #377.
Canada Pension Plan Investment Board first reported a position in AXSM in Q2 2020 and has held it in 8 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.
- Canada Pension Plan Investment Board held 225,400 shares of Axsome Therapeutics worth $55.2M as of Q2 2026.
- Canada Pension Plan Investment Board bought 134,000 Axsome Therapeutics shares in Q2 2026, an estimated $29.1M.
- Axsome Therapeutics made up 0.03% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #377 holding.
- Canada Pension Plan Investment Board first reported a position in Axsome Therapeutics in Q2 2020 and has held it in 8 quarters since.
- 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.